STOCK TITAN

GE HealthCare executive reports 3,780 shares and units

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) reports that Neal Joseph Sandy, CEO, Patient Care Solutions, had a direct position of 3,780 shares, including restricted stock units. It comprises 1,758 common shares and RSU grants of 775 and 1,247 units; each RSU represents one share at settlement. He also held employee stock options covering 20,000 shares at a $40.4000 exercise price and 13,773 shares at $88.6700. Both option positions are currently exercisable and expire in 2028.

Insider Sandy Neal Joseph
Role CEO, Patient Care Solutions
Type Security Shares Price Value
Holding Employee Stock Option (right to buy) F3 -- -- --
Holding Employee Stock Option (right to buy) F3 -- -- --
Holding Employee Stock Option (right to buy) F3 -- -- --
Holding Employee Stock Option (right to buy) F3 -- -- --
Holding Employee Stock Option (right to buy) F3 -- -- --
Holding Employee Stock Option (right to buy) F3 -- -- --
Holding Employee Stock Option (right to buy) F4 -- -- --
Holding Employee Stock Option (right to buy) F5 -- -- --
Holding Employee Stock Option (right to buy) F6 -- -- --
Holding Employee Stock Option (right to buy) F7 -- -- --
Holding Employee Stock Option (right to buy) F8 -- -- --
Holding Common Stock, par value $0.01 per share F1, F2 -- -- --
Holdings: Employee Stock Option (right to buy) — 70,652 options (Direct); Common Stock, par value $0.01 per share — 3,780 shares (Direct)
Footnotes (8)
  1. F1. Consists of (i) 1,758 shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock; (ii) 775 restricted stock units with respect to GE HealthCare common stock, granted on March 3, 2025, of which 381 will vest on September 3, 2027, and 394 will vest on September 3, 2028; and (iii) 1,247 restricted stock units with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
  2. F2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
  3. F3. Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the distribution of shares of GE HealthCare common stock by GE to holders of GE common stock on a pro rata basis, 100% of which is currently exercisable.
  4. F4. Award of an employee stock option with respect to GE HealthCare common stock, granted on February 1, 2023, of which 100% is currently exercisable.
  5. F5. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2023, of which 100% is currently exercisable.
  6. F6. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2024, of which 100% is currently exercisable.
  7. F7. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% became exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028.
  8. F8. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
Direct position 3,780 shares Includes common shares and restricted stock units.
Common shares 1,758 shares Included in the reported direct position.
Restricted stock unit grant 775 units Granted March 3, 2025; 381 vest September 3, 2027, and 394 vest September 3, 2028.
Restricted stock unit grant 1,247 units Granted March 2, 2026; vesting installments run from September 2, 2027, through September 2, 2029.
Employee stock options 20,000 underlying shares; $40.4000 exercise price Expires December 21, 2028; currently exercisable.
Employee stock options 13,773 underlying shares; $88.6700 exercise price Expires January 29, 2028; currently exercisable.
Employee stock options 1,837 underlying shares; $99.2100 exercise price Expires November 17, 2027.
Employee stock options 7,214 underlying shares; $63.5100 exercise price Expires March 2, 2030.
restricted stock units technical
"restricted stock units with respect to GE HealthCare common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Option (right to buy) technical
"Employee Stock Option (right to buy)"
currently exercisable financial
"100% is currently exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When do Neal Joseph Sandy’s GEHC restricted stock units vest?

The 775-unit grant vests 381 units on September 3, 2027, and 394 on September 3, 2028. The 1,247-unit grant vests 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Sandy Neal Joseph

(Last)(First)(Middle)
500 W. MONROE STREET

(Street)
CHICAGO ILLINOIS 60661

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
11/16/2026
3. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CEO, Patient Care Solutions
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.01 per share3,780(1)(2)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy) (3)11/17/2027Common Stock, par value $0.01 per share1,837$99.21D
Employee Stock Option (right to buy) (3)01/29/2028Common Stock, par value $0.01 per share13,773$88.67D
Employee Stock Option (right to buy) (3)12/21/2028Common Stock, par value $0.01 per share20,000$40.4D
Employee Stock Option (right to buy) (3)03/19/2029Common Stock, par value $0.01 per share4,971$57.74D
Employee Stock Option (right to buy) (3)04/11/2029Common Stock, par value $0.01 per share3,229$51.67D
Employee Stock Option (right to buy) (3)03/02/2030Common Stock, par value $0.01 per share7,214$63.51D
Employee Stock Option (right to buy) (4)02/01/2033Common Stock, par value $0.01 per share6,270$70.01D
Employee Stock Option (right to buy) (5)03/01/2033Common Stock, par value $0.01 per share3,705$75.3D
Employee Stock Option (right to buy) (6)03/01/2034Common Stock, par value $0.01 per share3,067$92.72D
Employee Stock Option (right to buy) (7)03/03/2035Common Stock, par value $0.01 per share3,307$86.45D
Employee Stock Option (right to buy) (8)03/02/2036Common Stock, par value $0.01 per share3,279$80.16D
Explanation of Responses:
1. Consists of (i) 1,758 shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock; (ii) 775 restricted stock units with respect to GE HealthCare common stock, granted on March 3, 2025, of which 381 will vest on September 3, 2027, and 394 will vest on September 3, 2028; and (iii) 1,247 restricted stock units with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
3. Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the distribution of shares of GE HealthCare common stock by GE to holders of GE common stock on a pro rata basis, 100% of which is currently exercisable.
4. Award of an employee stock option with respect to GE HealthCare common stock, granted on February 1, 2023, of which 100% is currently exercisable.
5. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2023, of which 100% is currently exercisable.
6. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2024, of which 100% is currently exercisable.
7. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% became exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028.
8. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading